Literature DB >> 30785018

Resveratrol exerts dose-dependent anti-fibrotic or pro-fibrotic effects in kidneys: A potential risk to individuals with impaired kidney function.

Shuyun Liu1, Meng Zhao1, Yijie Zhou1, Chengshi Wang1, Yujia Yuan1, Lan Li1, William Bresette2, Younan Chen1, Jingqiu Cheng1, Yanrong Lu3, Jingping Liu4.   

Abstract

BACKGROUND: Renal fibrosis is the pathological feature of chronic kidney disease (CKD) which leads to end-stage renal disease (ESRD) and renal failure. Resveratrol [3,5,4'-trihydroxy-trans-stilbene (RSV)] has shown benefits for metabolic diseases and anti-cancer therapy, but its potential risk on renal health has not been fully evaluated.
PURPOSE: To investigate the global effects of RSV on renal fibrosis in human tubular epithelial cell (TEC) line HK-2, and in mice with unilateral ureteral obstruction (UUO).
METHODS: A TGF-β-induced in vitro model of epithelial-mesenchymal transition (EMT) in TEC was established. The effects of RSV on cell viability, pro-fibrotic factors, oxidative stress, mitochondria function, and underlying pathway proteins were analyzed. In vivo, the effects of RSV on renal function and fibrosis were assayed in UUO mice.
RESULTS: Our results showed that low concentrations of RSV (5-20 μM) decreased TGF-β-induced EMT via Sirt1-dependent deacetylation of Smad3/Smad4 mechanism. By contrast, long-term (72 h) exposure to high concentrations of RSV (≥ 40 μM) promoted EMT in HK-2 cells via mitochondrial oxidative stress and ROCK1-mediated disordered cytoskeleton remodeling. In vivo, low-dose treatment of RSV (≤ 25 mg/kg) partly improved renal function, whereas high-dose treatment of RSV (≥ 50 mg/kg) lost its anti-fibrotic role and even aggravated renal fibrosis. However, mice with UUO were more susceptible to high RSV-induced renal injury than normal mice.
CONCLUSION: Dependent on dose, RSV activated either anti-fibrotic or pro-fibrotic effects in kidneys. The risk of RSV consumption in individuals with impaired kidney function should be carefully considered.
Copyright © 2018. Published by Elsevier GmbH.

Entities:  

Keywords:  Dose response; Epithelial-mesenchymal transition; Renal fibrosis; Resveratrol; Tubular epithelial cells

Mesh:

Substances:

Year:  2018        PMID: 30785018     DOI: 10.1016/j.phymed.2018.12.024

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  15 in total

1.  Flavin Oxidase-Induced ROS Generation Modulates PKC Biphasic Effect of Resveratrol on Endothelial Cell Survival.

Authors:  Anna Maria Posadino; Roberta Giordo; Annalisa Cossu; Gheyath K Nasrallah; Abdullah Shaito; Haissam Abou-Saleh; Ali H Eid; Gianfranco Pintus
Journal:  Biomolecules       Date:  2019-05-30

2.  Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction.

Authors:  Junju Zou; Xiaotao Zhou; Xian Chen; Yuerong Ma; Rong Yu
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

3.  Intestinal SIRT1 Deficiency-Related Intestinal Inflammation and Dysbiosis Aggravate TNFα-Mediated Renal Dysfunction in Cirrhotic Ascitic Mice.

Authors:  Yu-Te Chou; Tze-Tze Liu; Ueng-Cheng Yang; Chia-Chang Huang; Chih-Wei Liu; Shiang-Fen Huang; Tzu-Hao Li; Hsuan-Miao Liu; Ming-Wei Lin; Ying-Ying Yang; Tzung-Yan Lee; Yi-Hsiang Huang; Ming-Chih Hou; Han-Chieh Lin
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

Review 4.  Preventive Aspects of Early Resveratrol Supplementation in Cardiovascular and Kidney Disease of Developmental Origins.

Authors:  Chien-Ning Hsu; Chih-Yao Hou; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

Review 5.  Long non-coding RNAs: From disease code to drug role.

Authors:  Yuanyuan Chen; Zhaojun Li; Xiaoguang Chen; Sen Zhang
Journal:  Acta Pharm Sin B       Date:  2020-10-10       Impact factor: 11.413

Review 6.  Chemistry and Pharmacology of Cyperaceae Stilbenoids: A Review.

Authors:  Csilla Zsuzsanna Dávid; Judit Hohmann; Andrea Vasas
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

7.  Cordyceps cicadae Prevents Renal Tubular Epithelial Cell Apoptosis by Regulating the SIRT1/p53 Pathway in Hypertensive Renal Injury.

Authors:  Yi Shan Huang; Xu Wang; Zhendong Feng; Hailan Cui; Zebing Zhu; Chenhui Xia; Xueting Han; Wei Jing Liu; Yu Ning Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-13       Impact factor: 2.629

8.  Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with Schistosoma japonicum Infection.

Authors:  Tina Tuwen Chen; Shihyi Peng; Yanjuan Wang; Yuan Hu; Yujuan Shen; Yuxin Xu; Jianhai Yin; Congshan Liu; Jianping Cao
Journal:  Biomolecules       Date:  2019-10-25

9.  Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation.

Authors:  Megha Jhanji; Chintada Nageswara Rao; Mathew Sajish
Journal:  Geroscience       Date:  2020-11-27       Impact factor: 7.713

10.  Caffeic Acid, One of the Major Phenolic Acids of the Medicinal Plant Antirhea borbonica, Reduces Renal Tubulointerstitial Fibrosis.

Authors:  Bryan Veeren; Matthieu Bringart; Chloe Turpin; Philippe Rondeau; Cynthia Planesse; Imade Ait-Arsa; Fanny Gimié; Claude Marodon; Olivier Meilhac; Marie-Paule Gonthier; Nicolas Diotel; Jean-Loup Bascands
Journal:  Biomedicines       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.